top of page

PNEUMONIX MEDICAL RECEIVES NSF SBIR PHASE II GRANT

PneumoNIX has received follow-on Phase II grant from the NSF SBIR to continue the development of their proprietary technology.

29 views0 comments

Recent Posts

See All

PNEUMONIX MEDICAL RECEIVES NSF SBIR PHASE I GRANT

PneumoNIX Medical, a Baltimore-based medtech company focused on preventing complications associated with soft tissue biopsies, announced that it received Phase I SBIR grants from the NSF. The awards w

bottom of page